Pfizer begins first human tests for autoimmune disease drug
NCT ID NCT07235163
Summary
This is an early safety study to test a new medicine called PF-08065010, which is being developed for rheumatoid arthritis and lupus. The study will involve 100 healthy adults who will receive either the study medicine or a placebo injection or infusion. Researchers will monitor participants closely to see how their bodies handle the medicine and check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.